Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Point of Care: Innovations of the Future

23 Oct 2013 - 24 Oct 2013 - London, UK



Bookmark and Share


Join SMi's highly successful 10th annual Point of Care: Innovations of the Future conference promising to be a must see event!

SMi’s highly respected and eagerly anticipated 10th Annual Point of Care: Innovations of the Future conference comes to London for what promises to be a highly thought provoking and thrilling event. Join a plethora of highly respected speakers as they discuss topics ranging from the analysis of how the future of Point of Care testing will look and change over the next decade to the different strategies medical trusts are putting in place to increase the use of Point of Care testing within the patient care setting. Identify potential gaps in the market for new technologies and learn how to successfully implement these in a highly competitive market place.

This year’s Point of Care: Innovations of the Future conference will focus on technologies aimed at treating infectious diseases, with a focus on the rapid identification and ‘on the spot’ diagnosis of infectious diseases such as HIV and TB. This year’s event will take a look at what strategies different healthcare trusts are implementing to increase the usage of Point of Care testing and diagnosis at the site of the patient.

KEY TOPICS:

Identify key industry trends and market opportunities

Discover new technological applications and the latest advances in device technology

Learn how to overcome potential barriers to commercialisation of a new technology

Gain an insight into the future of POC technologies

Understand the benefits of non-invasive patient testing and how new profiling technologies lead to a better personalised treatment approach


EXPERT SPEAKERS INCLUDE:

Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, University of Edinburgh

Trevor Lewis, CEO, Medical Device Consultancy

Phil Lefebvre, Senior Manager, Business Development, Abbott Laboratories

Penny Wilson, Innovation Platform Leader, Technology Strategy

Roger Peck, Technical Officer, PATH

Tony Gibson, Scientific Director, North East Pathology Network Coordinator

David Huckle, Chief Executive, Adams Business Associates

Maurice O’Kane, Consultant Chemical Pathologist /Director for Research and Development, Western Health and Social Care Trust

Mohammad Al-Ubaydli, CEO, Patients Know Best

Kavita Oberoi, Founder and Managing Director, Oberoi Consulting

Gillian Hall, POCT Coordinator, Royal Brompton and Harefield NHS Foundation Trust

Per Simonsson, Professor of Clinical Chemistry, University Hospital MAS

Nigel Sansom, Senior Manager, Celaris Biosystems

Jose Manuel Costa, Associate Professor, University of Oviedo

Brian Winn, Partner, NHS Institute for Innovation and Improvement

John Rippeth, Principle Consultant, PA Consulting

Contact: Darryl Moxon, Phone: +44 20 7827 6066, Email: dmoxon@smi-online.co.uk

For Sponsorship opportunities contact Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk



Further information
Scientific News
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
Autism, Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!